Long-Term Clinical Follow-up of Sirolimus-Eluting (CYPHERâ¢) Coronary Stents in the Treatment of InStent Restenosis in an Unselected Population

Article ID	Journal	Published Year	Pages	File Type
2920000	Heart, Lung and Circulation	2007	7 Pages	PDF

Abstract

In conclusion, the use of S-E stents appears safe and efficacious in the treatment of an unselected population of BMS ISR with results comparing favourably with historical controls. Further randomised studies are needed to delineate the optimal management of this high risk group of patients.

Keywords

In-stent restenosis major adverse cardiac events percutaneous coronary intervention Coronary artery bypass graft

Related Topics

Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine

Preview

Long-Term Clinical Follow-up of Sirolimus-Eluting (CYPHERâ¢) Coronary Stents in the Treatment of InStent Restenosis in an Unselected Population

Authors

P.E. FRACP, D.W.M. MD, S.C. MScMed, D.W. FRACP, P.R. FRACP, S.H. PhD,